New developments at evosep to make clinical proteomics 100x more robust and 10x faster

J.P. Morgan Healthcare Conference – (January 8th, 2024) Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving science.

ViiV’s long-acting Cabenuva beats out daily oral HIV treatments in PhIII

ViiV Healthcare had already shown that its long-acting injectable Cabenuva was just as effective as daily oral treatments as well as preferred by patients for

February 22, 2024

Erectile Dysfunction Drugs Tied to Less Alzheimer’s Risk

Erectile dysfunction drugs were associated with reduced risk of Alzheimer’s disease, electronic health record (EHR) data from 270,000 men in the U.K. suggested. Over a

February 8, 2024

Discrimination Rampant in Healthcare; Spring COVID Booster? Lyme Disease Jumps 69%

Note that some links may require registration or subscription. Also please note that in observance of the upcoming holiday, Morning Break will not publish on

February 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.